About the 4th Congress of the GANSID
The GANSID Congress 2026 is a global gathering, bringing together clinicians, researchers, laboratory and/or translational scientists, patient organizations, industry partners, policymakers, and global health agencies.
Building on the success of previous virtual congresses, the GANSID Congress 2026 is the1st in-person Congress of the GANSID, offering a unique cross-disease platform focused on inherited blood disorders.
The 2026 Congress will focus on key scientific and health system priorities, including:
- Emerging therapies and curative approaches, including gene and cellular therapies
- Advances in transfusion medicine and comprehensive care
- Implementation science and health system integration in low- and middle-income countries
- Patient-centred outcomes, quality of life, and community engagement
